• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Kinetical analysis of pharmacodynamics based on drug-receptor interactions

Research Project

Project/Area Number 62460215
Research Category

Grant-in-Aid for General Scientific Research (B)

Allocation TypeSingle-year Grants
Research Field Physical pharmacy
Research InstitutionUniversity of Tokyo

Principal Investigator

HANANO Manabu  Faculty of Pharmaceutical Science University of Tokyo, 薬学部, 教授 (60012598)

Co-Investigator(Kenkyū-buntansha) SAWADA Yasufumi  Faculty of Pharmaceutical Science University of Tokyo, 薬学部, 助手 (80114502)
SUGIYAMA Yuichi  Faculty of Pharmaceutical Science University of Tokyo, 薬学部, 助教授 (80090471)
IGA Tatsuji  Department of Pharmacy University of Tokyo Hospital Faculty of Medicine Universi, 医学部, 助教授 (60012663)
FUKUDA Hideomi  Faculty of Pharmaceutical Science University of Tokyo, 薬学部, 教授 (50080172)
原島 秀吉  東京大学, 薬学部, 助手 (00183567)
Project Period (FY) 1987 – 1988
Project Status Completed (Fiscal Year 1988)
Budget Amount *help
¥6,300,000 (Direct Cost: ¥6,300,000)
Fiscal Year 1988: ¥700,000 (Direct Cost: ¥700,000)
Fiscal Year 1987: ¥5,600,000 (Direct Cost: ¥5,600,000)
KeywordsCardiac glycosides / Ouabain / Positive inotropic action / Na^+,K^+ ATPase / Isolated perfused heart / Brain / Glucose metabolism / ベンゾジアゼピンレセプター / Na^+ / K^+ATPase / ベンゾジアゼピン / Na^+,Ka^+ATPase
Research Abstract

1) At the molecular level, cardiac glycosides inhibit Na^+,K^+-ATPase, a membrane bound enzyme associated with the sodium pump. Since the sodium pump is necessary for maintenance of normal resting potential in most excitable cells, it is generally believed that at least a portion of the toxicity of digitals is caused by this enzyme-inhibiting action. It has been controversial whether this pump inhibition is the cause of positive inotropic action (PIA) of cardiac glycosides or just a parallel phenomenon. We then performed the kinetic analysis of the appearance process of PIA of ouabain in the rabbits by changing infusion rate. We also examined the specific binding of ouabain to Na^+,K^+-ATPase in the cardiac tissue homogenate, using rapid filtration method. In in vivo experiments, we measured the plasma concentration (Cp) and PIA of ouabain simultaneously, using 3H-ouabain and dp/dt, max as an index of PIA. Remarkable infusion rate dependency was found in th relationship between Cp and … More PIA. In addition the appearance process of PIA was kinetically the same as that of ouabain transfer from plasma compartment to peripheral compartment. This process could not be explained by the assumption that PIA is related to the single receptor and its occupation process is the rate limiting step of the appearance of PIA. It was made clear from in vitro binding experiments that the binding of ouabain to cardiac Na^+,K^+-ATPase is slow and classified into two types (high and low affinity). Then it is suggested that infusion rate rate dependet relationship between Cp and PIA may be explained by the model based on the two-receptors.
2) Local cerebral glucose (G) utilization was measured, using the double-label glucose analogue method, based on the brain disposition of 3H-3-0-methyl-glucose (M) and 14C-2-deoxy-glucose (D) in the brain region of awake mouse, at 1 hr after i.v. administration of clonazepam (0.01-1.0 mg/kg). After bolus i.v. injection of two compounds (M,D), time activity data of tracers in plasma (C^M,C^D) and regional brain were obtained. For cortex, the apparent volume of distribution (V^D for D, V^M for M), at 10 min after i.v. administration of D and M, were 0.64 0.07 (ml/g brain) and 0.33 0.03 (ml/g brain), respectively. The phosphorylation clearance (CL^D=(V^D-V^M)/theta) significangly decreased (30%) in the presence of clonazepam, whereas the lumped constant (LC;LC=LC , isotope-effect) did not change. The glucose metabolic rate (rCMRglc=CL^DXC^G/LC), in the presence of clonazepam, decreased (15%) in the regional brain. Thus, it should be possible to clearly visualize the sedative effects of benzodiazepine on regional brain function in vivo, using the double-label glucose analogue method. Less

Report

(3 results)
  • 1988 Annual Research Report   Final Research Report Summary
  • 1987 Annual Research Report
  • Research Products

    (14 results)

All Other

All Publications (14 results)

  • [Publications] Hideyoshi Harashima: Chem.Pharm.Bull.35. 2923-2927 (1987)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1988 Final Research Report Summary
  • [Publications] Hideyoshi Harashima: J.Pharmacobio-Dyn.11. 533-540 (1988)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1988 Final Research Report Summary
  • [Publications] Hideyoshi Harashima: Drug Metabolism and Disposition. 16. 645-649 (1988)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1988 Final Research Report Summary
  • [Publications] 伊藤清美: 薬物動態. 3. 564-565 (1988)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1988 Final Research Report Summary
  • [Publications] 石塚一志: 薬物動態. 3. 566-567 (1988)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1988 Final Research Report Summary
  • [Publications] Hideyoshi Harashima: "Infusion Rate-Dependent Positive Inotropic Action of Ouabain in Rabbits" Chem. Pharm. Bull. 35. 2923-2927 (1988)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1988 Final Research Report Summary
  • [Publications] Hideyoshi Harashima: "Kinetic Analysis of the Positive Inotropic Action(PIA) of Ouabain in Isolated Perfused Rabbit Hearts. Slow Onset of PIA and Slow Binding to Na^+, K^+-Adenosine Triphosphatase" J. Pharmacobio - Dyn. 11. 533-540 (1988)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1988 Final Research Report Summary
  • [Publications] Hideyoshi Harashima: "Nonlinear Tissue Distribution of Ouabain in Rabbits" Drug Metabolism and Dispositions. 16. 645-649 (1988)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1988 Final Research Report Summary
  • [Publications] Kiyomi Itoh: "Measurment of glucose utilization in the mouse brain" Xenobio Metabolism and Disposition. 3. 564-565 (1988)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1988 Final Research Report Summary
  • [Publications] Hitoshi Ishizuka: "Effect of Clonazepam on glucose utilization in the mouse brain" Xenobio Metabolism and Disposition. 3. 566-567 (1988)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1988 Final Research Report Summary
  • [Publications] 伊藤清美: 薬物動態. 3. 564-565 (1988)

    • Related Report
      1988 Annual Research Report
  • [Publications] 石塚一志: 薬物動態. 3. 566-567 (1988)

    • Related Report
      1988 Annual Research Report
  • [Publications] Hideyoshi>harashima: Chem.Pharm.Bull.35. 2923-2927 (1987)

    • Related Report
      1987 Annual Research Report
  • [Publications] 花野学: 薬物動態. 1. 23-42 (1986)

    • Related Report
      1987 Annual Research Report

URL: 

Published: 1987-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi